← Back to Search

Cialis + Flomax for Kidney Stones

Phase 4
Waitlist Available
Led By Jaime Landman, MD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this will be assessed immediately post-op as well as 3 months post-op.
Awards & highlights
All Individual Drugs Already Approved
Drug Has Already Been Approved
Pivotal Trial
Approved for 5 Other Conditions

Summary

This trial is testing whether using an alpha blocker or a phosphodiesterase inhibitor, alone or in combination, can help patients pass a larger ureteral access sheath during ureteroscopy for kidney stones.

Eligible Conditions
  • Kidney Stones
  • Kidney stones

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this will be assessed immediately post-op as well as 3 months post-op.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this will be assessed immediately post-op as well as 3 months post-op. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Passage of 16F Access Sheath
Secondary study objectives
Adverse events
Complications
Injury
+1 more

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Flomax + PlaceboActive Control1 Intervention
Patients will be prescribed Flomax 0.4Mg Capsule and given a bottle of placebo. They will be instructed to take 1 of each pill for the seven days prior to their surgery.
Group II: Cialis + PlaceboActive Control1 Intervention
Patients will be prescribed Cialis 5Mg tablet and given a bottle of placebo. They will be instructed to take 1 of each pill for the seven days prior to their surgery.
Group III: Cialis + FlomaxActive Control1 Intervention
Patients will be prescribed .4mg of Flomax and 5mg of Cialis. They will be instructed to take 1 of each pill for the seven days prior to their surgery.
Group IV: Placebo + PlaceboPlacebo Group1 Intervention
Given 2 bottles of placebo. They will be instructed to take 1 of each pill for the seven days prior to their surgery.

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
560 Previous Clinical Trials
1,929,882 Total Patients Enrolled
2 Trials studying Kidney Stones
3,315 Patients Enrolled for Kidney Stones
Jaime Landman, MDPrincipal InvestigatorUC Irvin Health
7 Previous Clinical Trials
800 Total Patients Enrolled
~26 spots leftby Nov 2025